Sign Up to like & get
recommendations!
0
Published in 2018 at "Amino Acids"
DOI: 10.1007/s00726-018-2684-6
Abstract: Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are endogenous inhibitors of nitric oxide (NO) synthase. SDMA is excreted in the urine without major metabolization. About 10% of daily produced ADMA are excreted unchanged in the…
read more here.
Keywords:
dimethylarginine;
dimethyl;
ddah activity;
citrulline ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Angiogenesis"
DOI: 10.1007/s10456-018-9617-6
Abstract: Nitric oxide (NO) has been strongly implicated in glioma progression and angiogenesis. The endogenous inhibitors of NO synthesis, asymmetric dimethylarginine (ADMA) and N-monomethyl-l-arginine (l-NMMA), are metabolized by dimethylarginine dimethylaminohydrolase (DDAH), and hence, DDAH is an…
read more here.
Keywords:
absence doxycycline;
assessment direct;
direct effects;
angiogenesis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Laboratory Investigation"
DOI: 10.1038/s41374-021-00541-5
Abstract: Dimethylarginine dimethylamino hydrolase-1 (DDAH-1) is an important regulator of nitric oxide (NO) metabolism that has been implicated in the pathogenesis of cardiovascular diseases. Nevertheless, its role in cerebral ischemia still needs to be elucidated. Herein,…
read more here.
Keywords:
blood brain;
adma;
ischemia;
brain barrier ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical science"
DOI: 10.1042/cs20190455
Abstract: BACKGROUND Contrast-induced acute kidney injury (CI-AKI) is one of the most common causes of hospital-acquired acute renal failure. However, the pathogenesis of CI-AKI remains unclear. Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase (NOS)…
read more here.
Keywords:
induced acute;
ddah;
injury;
contrast medium ... See more keywords